More Upside Possible for Biotech ETF

From its Feb. 25 to its April 14 lows, the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB) tumbled 21.2%. That fits the definition of a bear market and IBB’s decline, along those of the other biotech ETFs, received ample attention due in large part to talk that the biotech sector’s usually frothy...